Coronary Artery Bypass Grafting in Cancer Patients: Prevalence and Outcomes in the United States

Avirup Guha, Amit K. Dey, Ankur Kalra, Richard Gumina, Maryam Lustberg, Carl J. Lavie, Joseph F. Sabik, Daniel Addison

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Objective: To characterize the contemporary efficacy and utilization patterns of coronary artery bypass grafting (CABG) in specific cancer types. Methods: We leveraged the data from the National Inpatient Sample and plotted trends of utilization and outcomes of isolated CABG (with no other additional surgeries during the same hospitalization) procedures from January 1, 2003, through September 1, 2015. Propensity score matching was used to assess for potential differences in outcomes by type of cancer status among contemporary (2012–2015) patients. Results: Overall, the utilization of CABG decreased over time (250,677 in 2003 vs 134,534 in 2015, P.05). However, there was a significantly higher prevalence of major bleeding but not stroke in patients with breast and prostate cancer only compared with non-cancer CABG patients (P.05), except for breast cancer patients who had lower home care, but higher skilled care disposition (P
Original languageEnglish (US)
Pages (from-to)1865-1876
Number of pages12
JournalMayo Clinic Proceedings
Volume95
Issue number9
DOIs
StatePublished - Sep 1 2020

Fingerprint

Dive into the research topics of 'Coronary Artery Bypass Grafting in Cancer Patients: Prevalence and Outcomes in the United States'. Together they form a unique fingerprint.

Cite this